Matters of legal in nature including licensing, intellectual property, and lawsuits.
Common link is collaboration with Professor Stefan Hell Living T cell in suspension acquired with a Leica TCS SP8 STED 3X. 3D reconstruction of confocal and STED stacks clearly shows the gain in resolution by STED. Scale bar: 1 µm. Courtesy of Marco Fritsche, Mathias Clausen, and Christian Eggeling, MRC Human Immunology Unit, Weatherall Institute... Read more
Living T cell in suspension acquired with a Leica TCS SP8 STED 3X. 3D reconstruction of confocal and STED stacks clearly shows the gain in resolution by STED. Scale bar: 1 µm. Courtesy of Marco Fritsche, Mathias Clausen, and Christian Eggeling, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, UK. Goettingen... Read more
U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif., January 20, 2017 – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc.... Read more
Download PDF Read more
CHALFONT ST. GILES, UK – 3 January, 2017 – GE Healthcare’s Life Sciences business announced today that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and... Read more
Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more
Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more
November 28th 2016 – GE Healthcare has taken a 20% stake in global venture management company Pilot Lite Ventures (PLV), expanding its consulting business as it seeks to tap into an estimated $28 billion global market in unexploited healthcare and wellness R&D, orphaned IP and early-stage technology. GE Healthcare Partners currently offers analytics-based consulting solutions... Read more
UC San Francisco’s Center for Digital Health Innovation and GE Healthcare today announced a partnership to develop a library of deep learning algorithms – complex problem-solving formulas – that will empower clinicians to make faster and more effective decisions about the diagnosis and management of patients with some of the most common and complex medical... Read more
–Patent No. 1802752 “Parellel Patch Clamp System” Upheld in European Patent Office- Sunnyvale, California – October 7, 2016. Molecular Devices, LLC, a company committed to providing innovative analytical solutions for protein and cell biology, announced today that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in... Read more